Pharscin Competitors and Similar CompaniesClear all

Pharscin's competitors and similar companies include Sun Pharma, Torrent Pharmaceuticals and Hikma Pharmaceuticals.

	Pharscin Pharscin is a company that produces and sells drugs.	Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.	Torrent Pharmaceuticals Manufactures wide range of pharmaceutical products.	Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.
Founding Date	Founding Date 1996	Founding Date 1983	Founding Date 1971	Founding Date 1978
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare pharma	Tags Healthcare drug development pharma	Tags Healthcare pharma	Tags Healthcare pharma
Locations	Locations CN HQ	Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more	Locations Ahmedabad, IN HQ São Paulo, BR Nürnberg, DE 32 No Market, IN Bengaluru, IN Chennai, IN Dahej, IN see more	Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more
Employees	Employees 1,384	Employees 43,000	Employees 15,718	Employees 9,500
Valuation ($)	Valuation ($) 805.7 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 5.6 b
Financial
Revenue (est.)	Revenue (est.) ¥802m (FY, 2025)	Revenue (est.) ₹582.2b (FY, 2026)	Revenue (est.) ₹137.5b (FY, 2026)	Revenue (est.) $3.3b (FY, 2025)
Cost of goods	Cost of goods ¥350.5m (FY, 2025)	Cost of goods ₹115.4b (FY, 2026)	Cost of goods ₹33.9b (FY, 2026)	Cost of goods $1.7b (FY, 2025)
Gross profit	Gross profit ¥463.4m (FY, 2025)	Gross profit ₹488.9b (FY, 2026)	Gross profit ₹105b (FY, 2026)	Gross profit $1.7b (FY, 2025)
Net income	Net income ¥57.2m (FY, 2025)	Net income ₹115.6b (FY, 2026)	Net income ₹21.4b (FY, 2026)	Net income $407m (FY, 2025)